Basilea Pharmaceutica AG (BSLN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.305x

Based on the latest financial reports, Basilea Pharmaceutica AG (BSLN) has a cash flow conversion efficiency ratio of 0.305x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF39.03 Million ≈ $49.35 Million USD) by net assets (CHF127.94 Million ≈ $161.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BSLN equity financing ratio to measure how much of total assets are equity-financed.

Basilea Pharmaceutica AG - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Basilea Pharmaceutica AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Basilea Pharmaceutica AG (BSLN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Basilea Pharmaceutica AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Basilea Pharmaceutica AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mega First Corporation Bhd KLSE:3069	0.050x
Zhejiang Whyis Technology Co.Ltd. SHE:301218	N/A
ChengDa Pharmaceuticals Co. Ltd. SHE:301201	N/A
Liaoning Oxiranchem Inc SHE:300082	-0.012x
Viridien PA:VIRI	0.097x
Gokul Agro Resources Limited NSE:GOKULAGRO	0.069x
Mobilicom Limited Warrants NASDAQ:MOBBW	-0.038x
Beijing Asiacom Information Technology Co.Ltd SHE:301085	N/A

Annual Cash Flow Conversion Efficiency for Basilea Pharmaceutica AG (2002–2025)

The table below shows the annual cash flow conversion efficiency of Basilea Pharmaceutica AG from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Basilea Pharmaceutica AG (BSLN) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF127.94 Million ≈ $161.75 Million	CHF62.09 Million ≈ $78.50 Million	0.485x	-47.14%
2024-12-31	CHF81.00 Million ≈ $102.40 Million	CHF74.36 Million ≈ $94.01 Million	0.918x	+164.47%
2023-12-31	CHF-10.00 Million ≈ $-12.65 Million	CHF14.24 Million ≈ $18.01 Million	-1.424x	-318.08%
2022-12-31	CHF-20.71 Million ≈ $-26.19 Million	CHF7.06 Million ≈ $8.92 Million	-0.341x	-162.35%
2021-12-31	CHF-58.61 Million ≈ $-74.10 Million	CHF-32.02 Million ≈ $-40.48 Million	0.546x	+2.99%
2020-12-31	CHF-102.05 Million ≈ $-129.01 Million	CHF-54.13 Million ≈ $-68.44 Million	0.530x	-22.75%
2019-12-31	CHF-92.96 Million ≈ $-117.53 Million	CHF-63.84 Million ≈ $-80.71 Million	0.687x	-42.19%
2018-12-31	CHF-66.69 Million ≈ $-84.31 Million	CHF-79.21 Million ≈ $-100.14 Million	1.188x	+358.87%
2017-12-31	CHF-41.44 Million ≈ $-52.39 Million	CHF19.01 Million ≈ $24.04 Million	-0.459x	-121.41%
2016-12-31	CHF-35.00 Million ≈ $-44.25 Million	CHF-75.00 Million ≈ $-94.82 Million	2.143x	+146.97%
2015-12-31	CHF14.86 Million ≈ $18.78 Million	CHF-67.78 Million ≈ $-85.69 Million	-4.562x	-269.86%
2014-12-31	CHF57.93 Million ≈ $73.24 Million	CHF-71.46 Million ≈ $-90.35 Million	-1.234x	-47.01%
2013-12-31	CHF70.87 Million ≈ $89.60 Million	CHF-59.47 Million ≈ $-75.19 Million	-0.839x	-159.74%
2012-12-31	CHF105.50 Million ≈ $133.38 Million	CHF148.17 Million ≈ $187.33 Million	1.404x	+361.31%
2011-12-31	CHF153.27 Million ≈ $193.77 Million	CHF-82.38 Million ≈ $-104.15 Million	-0.537x	-205.96%
2010-12-31	CHF210.24 Million ≈ $265.80 Million	CHF106.64 Million ≈ $134.82 Million	0.507x	+143.29%
2009-12-31	CHF97.73 Million ≈ $123.56 Million	CHF-114.51 Million ≈ $-144.77 Million	-1.172x	-84.04%
2008-12-31	CHF199.74 Million ≈ $252.53 Million	CHF-127.17 Million ≈ $-160.77 Million	-0.637x	-170.10%
2007-12-31	CHF335.10 Million ≈ $423.66 Million	CHF-78.99 Million ≈ $-99.86 Million	-0.236x	+63.47%
2006-12-31	CHF112.31 Million ≈ $141.99 Million	CHF-72.47 Million ≈ $-91.62 Million	-0.645x	-415.05%
2005-12-31	CHF167.87 Million ≈ $212.23 Million	CHF34.38 Million ≈ $43.47 Million	0.205x	+166.86%
2004-12-31	CHF209.60 Million ≈ $264.99 Million	CHF-64.20 Million ≈ $-81.17 Million	-0.306x	+47.24%
2003-12-31	CHF90.29 Million ≈ $114.15 Million	CHF-52.42 Million ≈ $-66.28 Million	-0.581x	-13.63%
2002-12-31	CHF125.38 Million ≈ $158.51 Million	CHF-64.07 Million ≈ $-81.00 Million	-0.511x	--

About Basilea Pharmaceutica AG

SW:BSLN Switzerland Biotechnology

Market Cap

$813.10 Million

CHF643.14 Million CHF

Market Cap Rank

#10442 Global

#130 in Switzerland

Share Price

CHF52.40

Change (1 day)

+1.75%

52-Week Range

CHF44.90 - CHF58.60

All Time High

CHF108.80